Dolby Laboratories (NYSE:DLB) Announces Earnings Results, Beats Expectations By $0.29 EPS

Dolby Laboratories (NYSE:DLB) released its quarterly earnings data on Tuesday. The electronics maker reported $0.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.70 by $0.29, FiscalAI reports. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The company had revenue of $307.02 million during the quarter, compared to the consensus estimate of $305.76 million. During the same quarter in the prior year, the firm posted $0.61 earnings per share. Dolby Laboratories’s revenue for the quarter was up .7% on a year-over-year basis. Dolby Laboratories updated its FY 2026 guidance to 4.190-4.340 EPS and its Q1 2026 guidance to 0.790-0.940 EPS.

Dolby Laboratories Stock Performance

DLB stock opened at $65.13 on Wednesday. The stock has a market capitalization of $6.24 billion, a PE ratio of 23.86 and a beta of 0.97. The company has a fifty day moving average of $68.93 and a 200-day moving average of $72.51. Dolby Laboratories has a one year low of $64.02 and a one year high of $89.66.

Dolby Laboratories Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 10th. Stockholders of record on Tuesday, December 2nd will be paid a $0.36 dividend. This is a boost from Dolby Laboratories’s previous quarterly dividend of $0.33. The ex-dividend date is Tuesday, December 2nd. This represents a $1.44 annualized dividend and a dividend yield of 2.2%. Dolby Laboratories’s dividend payout ratio (DPR) is 48.35%.

Analyst Ratings Changes

A number of research analysts recently issued reports on DLB shares. Baird R W upgraded Dolby Laboratories to a “hold” rating in a research note on Friday, September 5th. Robert W. Baird began coverage on shares of Dolby Laboratories in a research report on Friday, September 5th. They set a “neutral” rating and a $74.00 target price on the stock. Barrington Research reiterated an “outperform” rating and issued a $100.00 price target on shares of Dolby Laboratories in a research report on Friday, September 12th. Wall Street Zen upgraded shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research note on Saturday, August 30th. Finally, Tigress Financial raised their price objective on shares of Dolby Laboratories from $112.00 to $114.00 and gave the stock a “buy” rating in a research report on Friday, August 15th. Three research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $93.25.

Insider Transactions at Dolby Laboratories

In other Dolby Laboratories news, SVP Shriram Revankar sold 7,000 shares of Dolby Laboratories stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $74.92, for a total value of $524,440.00. Following the sale, the senior vice president owned 70,435 shares of the company’s stock, valued at approximately $5,276,990.20. The trade was a 9.04% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Kevin J. Yeaman sold 25,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 14th. The stock was sold at an average price of $68.87, for a total value of $1,721,750.00. Following the transaction, the chief executive officer owned 114,725 shares in the company, valued at $7,901,110.75. The trade was a 17.89% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 57,000 shares of company stock valued at $4,037,690. 38.39% of the stock is owned by insiders.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. Aquatic Capital Management LLC purchased a new stake in shares of Dolby Laboratories during the 3rd quarter worth $56,000. iSAM Funds UK Ltd acquired a new stake in shares of Dolby Laboratories in the third quarter valued at about $68,000. Advisory Services Network LLC purchased a new stake in Dolby Laboratories during the third quarter worth about $102,000. US Bancorp DE boosted its holdings in Dolby Laboratories by 31.3% during the third quarter. US Bancorp DE now owns 1,429 shares of the electronics maker’s stock worth $103,000 after buying an additional 341 shares in the last quarter. Finally, Osaic Holdings Inc. grew its position in Dolby Laboratories by 165.8% during the second quarter. Osaic Holdings Inc. now owns 2,541 shares of the electronics maker’s stock worth $195,000 after buying an additional 1,585 shares during the period. Hedge funds and other institutional investors own 58.56% of the company’s stock.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.